When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VTGN - Vistagen Therapeutics: A Pipeline With Potential In Anxiety And Depression
VistaGen Therapeutics Inc.
2024-04-24 10:33:24 ET
Summary
Vistagen Therapeutics, Inc. is developing a pipeline of drugs centered around pherines, odorless, neuroactive steroids that act through sensory neurons in the nose.
The company has seen impressive results from a phase 3 study of PH94B in patients with social anxiety disorder, leading to a significant increase in stock value.
Vistagen Therapeutics is also exploring the potential of PH10, or itruvone, in treating major depressive disorder, with plans for a phase 2b study.